BIBLIOGRAFIA
Accapezzato D., Visco V., Francavilla V., Molette C., Donato T., Paroli M., Mondelli MU., Doria M., Torrisi MR., Barnaba V. 2005. Chloroquine enhances human CD8+T cell responses against solubile antigens in vivo. Jem. 202: 817-826.
Almeida M.C., Silva A.C., Barral A., Barral-Netto M. 2000. A simple method for human peripheral blood monocyte isolation. Mem. Inst. Oswaldo Cruz 95, 221.
Akiyama Y., Stevenson G.W., Schilick E., Matsushima K., Miller P.J. and Stevenson H.C. 1985. Differential ability of human blood monocyte subsets to release various cytokines. J. Leukocyte Biol. 37: 519.
Bancherau J., De Saint-Vis B., Fugier-Vivier I., Massacrier C., Gaillard C., Vanbervliet B., Ait-Yahia S., Liu Y.J., Lebecque S., Caux C. 1998. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and node of activation. J.Immunol., 160(4): 1666-76.
Banchereau j., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendron B., Palucka K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 : 767-811.
Banchereau J., Palucka K. 1999. Dendritic cells: a link between innateand adaptive immunity .J. Clin. Immunol. 49 (4) : 355-361.
Banchereau J., Steinman RM. 1998. Dendritic cells and the control of immunity. Nature. 392: 245-252.
Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Zozzini F. 1995. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol
Rev. 8: 87-112.
Bevan M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assey. J. Exp. Med. 143: 1283-88.
Bienzle D., Reggeti F., Clark M.E., and Chow C. 2003. Functional feline dendritic cells derived from blood and bone marrow. Vet. Immunol. Immunopathol. 96: 19-30.
Brown M.S. and Goldstein J.L. 1983. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis. Annu. Rev Biochem. 52: 223.
Caux C., Dezutter-Dambuyant C., Schmitt D., Banchereau J. 1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langherans cells. Nature, 360 (6401): 258-261.
Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity : T-T help via APC activation. J. Exp. Med. 184: 747.
Crowley M., Inaba K., Steinman RM. 1990 .Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreigns protein. J. Exp. Med. 172: 383-386.
De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., Urbain J., Leo O., and Moser M. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184: 1413-1424.
Dunham S.P. and Bruce J. 2004. Isolation, expression and bioactivity of feline granulocyte-macrophage colony-stimulating factor. Gene 332: 97-106.
Elder J.H., Dean G.A, Hoover E.A, et al. 1998 Lesson from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res. Hum. Retrovir. 14: 797-801.
Fanger N.A., Maliszweski CR., Schooley K., Griffth TS. 1999. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis–inducing ligand (TRAIL). J. Exp. Med. 190 (8): 1155-64.
Figdor C.G., De Vries L.J., Lesterhuis W.J. and Melief C.J. 2004. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10: 475-480.
Fluks A.J., 1981. Three-step isolation of human blood monocytes using discontinuous density gradients of Percoll. J. Immunol. Methods 41, 225-233.
Freer, G., Florio W., Dalla Casa B., Bottai D., Batoni G., Maisetta G., Senesi S. and Campa M. 1998. Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. Res. Microbiol. 149:265-275.
Gatti E., Velleca M.A., Biedermann B.C, Ma W., Unternaehrer J., Ebersold M.W., Medzhitov R., Pober J.S. and Mellman L. 2000. Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J. Immunol. 164: 3600-3607.
Geijtenbeek T.B., Torensma R., Van Vliet S.J., Van Duijnhoven G.C., Adema G.J., Van Kooyk Y. and Figdor C.G. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:5 75-585.
Granelli-Piperno A., Golebiowska A., Trumpfheller C., Siegal F.P., Steinman R.M. 2004. HIV-1-infected monocyte-drerived dendritic cell do not undergo maturation but canelicit IL-10 production and T cell regulation. PNAS 101:7669-7674.
Harari A., Petitpierre S., Vallelian F. and Pantaleo G. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1 infected subjets with progressive disease: changes after antiretroviral terapy. Blood. 103: 966-972.
Heath WR. and Carbone FR. 2001. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 19:47-64.
Hoover E.A, Sprague W.S, Pope M. 2005. Colture and comparison of feline myeloid dendritic cells vs macrophages. J. Comp. Path 133, 136-145.
Inaba K., Inaba M., Naito M., Steinman RM. 1993. Dendritic cells progenitors phagocytose particulates, including bacillus Calmette-Guarin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178: 479-488.
Inaba K., Witmer-Pack M., Inaba M., et al. 1994. The tissue distribution of the B7.2 costimulator in mice: Abundant expression on dendritic cells in situ and during maturation in vitro. J. Exp. Med. 180:1849-1860.
Inaba K., Turley S., Yamaide F., et al. 1998. Efficient presentation of phagocytosed cellular fragments on the MHC class II products of dencritic cells. J. Exp. Med. 188: 2163-2173.
Jego G., Palucka AK., Black JP, Chatouni C., Pascual V., Banchereau J. 2003. Plasmacytoid Dendritic cells induce plasma cell differentiation through type I interferon and interleukine 6. Immunity. 19 (2): 225-34.
Jonuleit H., Giesecke-Tuettenberg A., Tuting T., Thurner-Schuler B., Stuge T.B., Paragnik L., Kandemir A., Lee P., Schuler G., Knop J., Enk A.H. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of
melanoma-specific T-cells responsesin humans following intranodal injection. Inte. J. Cancer 93, 243-251.
Kalinski P., Hilkens M.C., Snijders A., Snijdewint F.G., and Kapsenberg M.L. 1997. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv. Rxp. Med. Biol. 417:363-7:363.
Labeur M.S., Roters B., Pers B., Mehling A., Luger T.A., Schwarz T., Grabbe S. 1999. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cells maturation stage. J.of immunology, 162:168-175.
Lanzavecchia A, Cella M., Facchetti F., Colonna M. 2000. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Immunol. nature. vol.1 no. 4 305-309.
Lapenta C., et al. 2003. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactived virus-pulsed dendritic cells generated in the presence of IFN alpha. J. Exp. Med. 198, 361-367.
Lechmann M., Krooshoop J.E.B.D., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., Schuler G., Steinkasserer A. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194 (12): 1813- 1821.
Lehner M., Holter W. 2002. Endotoxin-free purification of monocytes for dendritic cells geeration via discontinuous density gradient centrifugation based on diluted Ficoll-Paque plus. Int. Arch. Allergy Immunol. 128, 73.
Lindquist R.L., Shakhar G., Dudziak D., Wardemann H., Eisenreich T., Dustin M.L., and Nussenzweig M.C. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5: 1243-50.
Lu G., Janjic BM., Janjic J., Whiteside TL., Storkus WJ ., Vujanovic nL. 2002. Innate direct anticancer effector function of humane immature dendritic cells II. Role of TNF, lymphotoxina-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol., 168 (4): 1823-30.
Lu, W., Wu X., Lu Y., Guo W., and Andrieu J.M. 2003. Therapeutic dendritic-cell vaccine for simian AIDS. Nat. Med. 9: 27-32.
Lu, W., Arraes L.C., Ferreira W.T., Andrieu J.M. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10: 1359-1365.
Luft T., Pang K.C., Thomas E., Hertzog P., Hart D.N.J., Trapani J. and Cebon J. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161: 1947.
Mackensen A., Drager R., Schlesier M., Mertelsmann R., Lindemann A. 2000. Presence of IgE antibodies to bovine serum in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol. Immunother. 49: 152-156.
Malhotra U et al. 2000. Effect of combination antiretroviral terapy on T-cell immunity in acute human immunodeficiency virus type 1 infection. J. Infect. Dis. 181, 121-131.
Manetti R., Annunziato F., Tomasevic L., Gianno V., Parrochi P., Romagnani S., and Maggi E. 1995. Polyinosinic acid:polycitidylic acid promotes T helper Type 1-specific immune responses by stimulating macrophage production of interferon-α and interleukine-12. Eur. J. Immunol. 25: 2656.
Mariotti A., Rutella S., Pierelli L., Bonanno C., Sica S., Ameglio F., Capuolongo E., cambia G., d’Onofrio G., Leone G. 2002. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100 (7): 2562-71.
Martison J., Bea J., Klingermann H.G., Tan Y. 2004. Activated platlets rapidilly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC. Cytotherapy. 6 (5): 487-497.
Mellroy D., et al. 1998. Low CD83, but normal MHC class II and costimoltatory molecule expression, on spleen dendritic cells from HIV+ patients. AIDS Res. Hum. Retroviruses. 14, 505-513.
Muller G., Muller A., Jonuleit H., Steinbrink K., Szalma C., Paragnik L., Lignau E., Schimidt E., Knop J., and Enk A.H. 2000. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J. Invest. Dermatol. 14: 142-149.
Nair, S., McLaughlin C., Weizer A., Su Z., Boczkowski D., Dannull J., Vieweg J., and Gilboa E. 2003. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 1: 6275-6282.
Nestle F.O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadedorf D. 1998. Vaccination of melanoma patients with peptide or tumor lysate pulsed dendritic cells. Nat. Med. 4, 328-332.
O'Neill, D. and N. Bhardwaj. 2005. Exploiting dendritic cells for active immunotherapy of cancer and chronic infection. Methods Mol. Med. 109: 1-18.
Oxenius A., et al. 2000. Early highly active antiretroviral terapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA. 97, 3382-3387.
Pacanowski J., et al. 2001. Reduced blood CD123+ (lyphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV infection. Blood. 98, 3016-3021.
Paillot, R., Laval F., Audonnet J.-C., Andreoni C., Juillard V. 2001. Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes. Immunology 102: 396-404.
Park Y.G., Moon H.J., Kim J. 2006. A comparative study of magnetic-activated cell sorting,cytotoxicity and preplating for the purification of human myoblasts. Y. Med. Journal ,vol. 47, no 2, 179-183.
Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. 1987. Isolation of T lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.
Science, 235: 790-3.
Pertoft H., Laurent T.C., Laas T., Kogedal L. 1978. Density gradients prepared from colloidal silica particles coated by polyvinylpyrrolidone (percoll). Anal. Biochem. 88, 271-282.
Qing Yi, Desikan R., Barbogie B. and Munshi N. 2001. Optimizing dendritc cell-based immunotheraphy in multiple myeloma. Britis Journal of Haematology. 117, 297-305.
Repnik U., Knezevic M., Jeras M. 2003. Simple and cost-effective isolation of monocytes from buffy coats. J. of Imm. Methods 278, 283-292.
Robinson R.A., De Vita V.T., Levy H.B, Baron S., Hubbard S.P., and Levine A.S. 1976. A phase I-II trial of multiple dose polyriboinosinic polyribocytidylic acid I patients with leukemia or solid tumor. J. Natl. Cancer .Inst. 57: 599.
Rock K.L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17: 131-137.
Romani N., Koide S., Crowley M., Witmer-Pack M., Livingstone A.M., Fathmann C.G., Inaba K and Steinman R.M. 1989. Presentation of exogeneous protein antigens by dendritic cells to T cell clones. J. Exp. Med. 179: 1109.
Romani, N., Reider D., Heuer M., Ebner S., Kampgen E., Eibl B., Niederwieser D., Schuler G. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Meth. 196: 137-151.
Rosemberg E.S., et al. 1997. Vigorous HIV-1 specific CD4+ T cell responses associated with control of viremia. Science. 278, 1447-1450.
Saint-André Marchal I:C., Dezutter-Dambuyant J.P., Martin B.J, et al. 1997. Quantitative assessment of feline epidermal Langerhans cells. Britisch J. Dermatol. 136 : 961-963.
Salazar A.M., Levy H.B., Ondra S., Kende M., Sherokman B., Brown D., Mena H., Martin N., Schwab K., Donovan D., et al. 1996. Long-ter treatament of malignant gliomas with intamuscolarly administered polynosinic-polycitidylic acid stabilized with polylysine and carboxymethylcellulose: and open pilot study. Neurosurgery. 38: 1096.
Sallusto, F., A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage-colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor-a. J. Exp. Med. 179: 1109-1118.
Sallusto F., Cella M., Danielli C., Lanzavecchia A. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 12: 389-400.
Sallusto, F., A. Lanzavecchia. 2002. The instructive role of dendritic cells on T-cell responses. Arthritis Res. 4: S127-S132.
Santini S:M., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T., Belardelli F. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. EXP. Med. 15: 1777-1788.
Scheinecker C., Machold K.P., Majdic O., Hocker P., Knapp W., Smolen J.S. 1998. Initiation of the autologous mixed lymphocyte reaction requires the exspression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. J. Immunol. 161: 3966-3973.
Schijns, V.E. 2000. Immunological concepts of vaccine adjuvant activity. Curr. Opin. Immunol. 12: 456–463.
Schuler G., Thurner-Schuler B., Dieckman D., Keikavoussi P., Bender A., Maczek C., Jonuleit H., Roder C., Haendle I., LeisgangW., Dunbar R., Cerundolo V., Von den Driesch P., Knop J., Brocker E.B., Enk A., Kampgen E.
2000. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducuble in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J. of immunology, 165: 3492-3496.
Schulz O., Diebold S.S., Chen M., Naslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.T., Flavell R.A., Liljestrom P., Reis C and Sousa. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 433: 887-892.
Shortmann K., Luft T., Luetjens P., Hochrein H., Toy T., Masterman K.A., Rizkalla M., Maliszewski C., Cebon J., Maraskovsky E. 2002.IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. Int.Immunol. 14 (4): 367-80.
Steinman R.M, Cohn Z.A. 1973. Identification of a novel cell type in peripheral lymphoid organs of mice. I .Morphology, quantitation, tissue distribution. J. Exp. Med. 137: 1142-1162.
Steinman R.M. 1991. The dendritic cell system and its role in immunogecity. Annu. Rev. Immunol. 9:271.
Steinman R.M. 2001. Dendritic cells and the control of immunity:Enhancing the efficiency of antigen presentation. The Mount S. J. of Med. Vol. 68 no. 3.
Steinman RM., Pope M. 2002. Exploting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109 (12): 1519-1526.
Steinman R.M., Hawiger D., Nussenzweig M.C. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21: 685-711.
Théry C. and Amigorena S. 2001. The cell biology of antigen presentation in dendritic cells. Els. Science Ltd. 13: 45-51.
Tompkins M.B., Bull M.F., Dow J.L., Ball J.M., Collisson E.W., Winslow B.J., Phadke A.P., Vahlenkamp T.W., Tompkins W.A. 2002. Feline immunodeficiency virus infection is characterized by B7+CTLA4+T cell apoptosis. J. Infect. Dis. 185: 1077-1093.
Trinchieri G. 1998. Interleukin-12: a cytokine at the interface of infiammation and immunity. Adv. Immunol. 70-83.
Trumpfheller C., Park C.G., Finke J., Steinman R., Piperno A. 2003. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Intern. Immunol. 15 (2): 289-298.
Turley SJ., Inaba K., Garrett WS., et al. 2000. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288: 522-527.
Yamamoto J.K., OkudaT., Ackley C.D., Louie H., Pembroke E., Zochlinski H., Munn R.J., Gardner M.B. 1991. Experimantal vaccine protection against feline immunodeficiency virus. AIDS Res HumRetroviruses.7: 911-22.
Yewdell J.W., Norbury C.C., Bennink J.R. 1999. Mechanism of exogeneous antigen presentation by MHC class I molecules in vitro and in vivo:implication for generating CD8+ T cells responses to infectious agents,tumor,transplants and vaccines. Adv. Immunol. 73: 1-77.
Yoshida I., Azuma M., Kawai H., Fischer H.W. and Suzutani T. 1992. Identification of call membrane receptor for interferon induction by poly rI:rC. ACta Virol. 36:347.
Yoshida A., et al. 2003. Induction of protective immune responses against R5 human immunodeficiency virus type I (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1 pulsed dendritic cells: possible involvement of a novel factor of human CD4+ t cell origin. J. Virol. 77, 8719-8728.
Verdijk R. M., T. Mutis, B. Esendam, J. Kamp, C. J. M. Melief, A. Brand, E. Goulmy. 1999. Polyriboinosinic polyribocytidylic acid (Poly(I:C) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163: 57–61.
Zhou L.J., Tedder T.F. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154: 3821-3829.
Zhou, L.J., Tedder T.F. 1996. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 93: 2588-2592.
